Global Exenatide Market Growth (Status and Outlook) 2025-2031

December 2025 | 70 pages | ID: GFF63F7AECEEN
LP Information

Abstracts

According to this study, the global Exenatide market size will reach US$ 129 million by 2031.

Exenatide (marketed as Byetta, Bydureon) is a glucagon-like peptide-1 receptor agonist (GLP-1 receptor agonist) medication, belonging to the group of incretin mimetics, approved in April 2005 for the treatment of diabetes mellitus type 2.

Exenatide is a medication used in the treatment of type 2 diabetes mellitus. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which stimulates insulin secretion and reduces glucagon secretion in a glucose-dependent manner. There are several factors that contribute to the market drive for exenatide: Exenatide has been shown to effectively lower blood glucose levels, improve glycemic control, and reduce HbA1c levels in patients with type 2 diabetes. It is also associated with weight loss, which is beneficial for overweight or obese patients. The medication has a positive impact on cardiovascular health by reducing the risk of myocardial infarction and stroke. As a GLP-1 agonist, exenatide mimics the physiological effects of incretin hormones, which are released in response to food ingestion. It enhances the body's natural response to food by increasing insulin secretion, suppressing glucagon secretion, and delaying gastric emptying. The medication's unique mechanism of action sets it apart from other diabetes medications, and it is considered a valuable treatment option for patients who are not achieving glycemic control with other medications. Exenatide is administered by subcutaneous injection, once or twice daily, and can be self-administered by patients. The medication's convenient dosing schedule and ease of use make it a popular choice among patients and healthcare providers. The prevalence of diabetes is increasing globally, and there is a significant unmet need for effective and well-tolerated treatment options. Exenatide is gaining market acceptance as a result of its proven efficacy, safety, and convenience. The medication is approved for use in several countries, including the United States, Europe, and Japan. Exenatide is protected by patents, which contribute to the medication's market drive by limiting competition and ensuring market exclusivity. The medication's patent protection has helped to maintain its market position and secure its profitability for the pharmaceutical companies that manufacture it.

LPI (LP Information)' newest research report, the “Exenatide Industry Forecast” looks at past sales and reviews total world Exenatide sales in 2024, providing a comprehensive analysis by region and market sector of projected Exenatide sales for 2025 through 2031. With Exenatide sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Exenatide industry.

This Insight Report provides a comprehensive analysis of the global Exenatide landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Exenatide portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Exenatide market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Exenatide and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Exenatide.

This report presents a comprehensive overview, market shares, and growth opportunities of Exenatide market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Extended-release injectable suspension
• Fast release injectable suspension

Segmentation by Application:

• Hospital
• Drug store

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• AstraZeneca
• Byetta
• guangzhou tosun pharmaceutical co. ltd.
• Fierce Pharma
• MIMS Hong Kong

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Exenatide Market Size (2020-2031)
  2.1.2 Exenatide Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Exenatide by Country/Region (2020, 2024 & 2031)
2.2 Exenatide Segment by Type
  2.2.1 Extended-release injectable suspension
  2.2.2 Fast release injectable suspension
2.3 Exenatide Market Size by Type
  2.3.1 Exenatide Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Exenatide Market Size Market Share by Type (2020-2025)
2.4 Exenatide Segment by Application
  2.4.1 Hospital
  2.4.2 Drug store
2.5 Exenatide Market Size by Application
  2.5.1 Exenatide Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Exenatide Market Size Market Share by Application (2020-2025)

3 EXENATIDE MARKET SIZE BY PLAYER

3.1 Exenatide Market Size Market Share by Player
  3.1.1 Global Exenatide Revenue by Player (2020-2025)
  3.1.2 Global Exenatide Revenue Market Share by Player (2020-2025)
3.2 Global Exenatide Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 EXENATIDE BY REGION

4.1 Exenatide Market Size by Region (2020-2025)
4.2 Global Exenatide Annual Revenue by Country/Region (2020-2025)
4.3 Americas Exenatide Market Size Growth (2020-2025)
4.4 APAC Exenatide Market Size Growth (2020-2025)
4.5 Europe Exenatide Market Size Growth (2020-2025)
4.6 Middle East & Africa Exenatide Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Exenatide Market Size by Country (2020-2025)
5.2 Americas Exenatide Market Size by Type (2020-2025)
5.3 Americas Exenatide Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Exenatide Market Size by Region (2020-2025)
6.2 APAC Exenatide Market Size by Type (2020-2025)
6.3 APAC Exenatide Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Exenatide Market Size by Country (2020-2025)
7.2 Europe Exenatide Market Size by Type (2020-2025)
7.3 Europe Exenatide Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Exenatide by Region (2020-2025)
8.2 Middle East & Africa Exenatide Market Size by Type (2020-2025)
8.3 Middle East & Africa Exenatide Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL EXENATIDE MARKET FORECAST

10.1 Global Exenatide Forecast by Region (2026-2031)
  10.1.1 Global Exenatide Forecast by Region (2026-2031)
  10.1.2 Americas Exenatide Forecast
  10.1.3 APAC Exenatide Forecast
  10.1.4 Europe Exenatide Forecast
  10.1.5 Middle East & Africa Exenatide Forecast
10.2 Americas Exenatide Forecast by Country (2026-2031)
  10.2.1 United States Market Exenatide Forecast
  10.2.2 Canada Market Exenatide Forecast
  10.2.3 Mexico Market Exenatide Forecast
  10.2.4 Brazil Market Exenatide Forecast
10.3 APAC Exenatide Forecast by Region (2026-2031)
  10.3.1 China Exenatide Market Forecast
  10.3.2 Japan Market Exenatide Forecast
  10.3.3 Korea Market Exenatide Forecast
  10.3.4 Southeast Asia Market Exenatide Forecast
  10.3.5 India Market Exenatide Forecast
  10.3.6 Australia Market Exenatide Forecast
10.4 Europe Exenatide Forecast by Country (2026-2031)
  10.4.1 Germany Market Exenatide Forecast
  10.4.2 France Market Exenatide Forecast
  10.4.3 UK Market Exenatide Forecast
  10.4.4 Italy Market Exenatide Forecast
  10.4.5 Russia Market Exenatide Forecast
10.5 Middle East & Africa Exenatide Forecast by Region (2026-2031)
  10.5.1 Egypt Market Exenatide Forecast
  10.5.2 South Africa Market Exenatide Forecast
  10.5.3 Israel Market Exenatide Forecast
  10.5.4 Turkey Market Exenatide Forecast
10.6 Global Exenatide Forecast by Type (2026-2031)
10.7 Global Exenatide Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Exenatide Forecast

11 KEY PLAYERS ANALYSIS

11.1 AstraZeneca
  11.1.1 AstraZeneca Company Information
  11.1.2 AstraZeneca Exenatide Product Offered
  11.1.3 AstraZeneca Exenatide Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 AstraZeneca Main Business Overview
  11.1.5 AstraZeneca Latest Developments
11.2 Byetta
  11.2.1 Byetta Company Information
  11.2.2 Byetta Exenatide Product Offered
  11.2.3 Byetta Exenatide Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Byetta Main Business Overview
  11.2.5 Byetta Latest Developments
11.3 guangzhou tosun pharmaceutical co. ltd.
  11.3.1 guangzhou tosun pharmaceutical co. ltd. Company Information
  11.3.2 guangzhou tosun pharmaceutical co. ltd. Exenatide Product Offered
  11.3.3 guangzhou tosun pharmaceutical co. ltd. Exenatide Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 guangzhou tosun pharmaceutical co. ltd. Main Business Overview
  11.3.5 guangzhou tosun pharmaceutical co. ltd. Latest Developments
11.4 Fierce Pharma
  11.4.1 Fierce Pharma Company Information
  11.4.2 Fierce Pharma Exenatide Product Offered
  11.4.3 Fierce Pharma Exenatide Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Fierce Pharma Main Business Overview
  11.4.5 Fierce Pharma Latest Developments
11.5 MIMS Hong Kong
  11.5.1 MIMS Hong Kong Company Information
  11.5.2 MIMS Hong Kong Exenatide Product Offered
  11.5.3 MIMS Hong Kong Exenatide Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 MIMS Hong Kong Main Business Overview
  11.5.5 MIMS Hong Kong Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Exenatide Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Exenatide Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Extended-release injectable suspension
Table 4. Major Players of Fast release injectable suspension
Table 5. Exenatide Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Exenatide Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Exenatide Market Size Market Share by Type (2020-2025)
Table 8. Exenatide Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Exenatide Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Exenatide Market Size Market Share by Application (2020-2025)
Table 11. Global Exenatide Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Exenatide Revenue Market Share by Player (2020-2025)
Table 13. Exenatide Key Players Head office and Products Offered
Table 14. Exenatide Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Exenatide Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Exenatide Market Size Market Share by Region (2020-2025)
Table 19. Global Exenatide Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Exenatide Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Exenatide Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Exenatide Market Size Market Share by Country (2020-2025)
Table 23. Americas Exenatide Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Exenatide Market Size Market Share by Type (2020-2025)
Table 25. Americas Exenatide Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Exenatide Market Size Market Share by Application (2020-2025)
Table 27. APAC Exenatide Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Exenatide Market Size Market Share by Region (2020-2025)
Table 29. APAC Exenatide Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Exenatide Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Exenatide Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Exenatide Market Size Market Share by Country (2020-2025)
Table 33. Europe Exenatide Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Exenatide Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Exenatide Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Exenatide Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Exenatide Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Exenatide
Table 39. Key Market Challenges & Risks of Exenatide
Table 40. Key Industry Trends of Exenatide
Table 41. Global Exenatide Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Exenatide Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Exenatide Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Exenatide Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. AstraZeneca Details, Company Type, Exenatide Area Served and Its Competitors
Table 46. AstraZeneca Exenatide Product Offered
Table 47. AstraZeneca Exenatide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. AstraZeneca Main Business
Table 49. AstraZeneca Latest Developments
Table 50. Byetta Details, Company Type, Exenatide Area Served and Its Competitors
Table 51. Byetta Exenatide Product Offered
Table 52. Byetta Exenatide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Byetta Main Business
Table 54. Byetta Latest Developments
Table 55. guangzhou tosun pharmaceutical co. ltd. Details, Company Type, Exenatide Area Served and Its Competitors
Table 56. guangzhou tosun pharmaceutical co. ltd. Exenatide Product Offered
Table 57. guangzhou tosun pharmaceutical co. ltd. Exenatide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. guangzhou tosun pharmaceutical co. ltd. Main Business
Table 59. guangzhou tosun pharmaceutical co. ltd. Latest Developments
Table 60. Fierce Pharma Details, Company Type, Exenatide Area Served and Its Competitors
Table 61. Fierce Pharma Exenatide Product Offered
Table 62. Fierce Pharma Exenatide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Fierce Pharma Main Business
Table 64. Fierce Pharma Latest Developments
Table 65. MIMS Hong Kong Details, Company Type, Exenatide Area Served and Its Competitors
Table 66. MIMS Hong Kong Exenatide Product Offered
Table 67. MIMS Hong Kong Exenatide Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. MIMS Hong Kong Main Business
Table 69. MIMS Hong Kong Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Exenatide Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Exenatide Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Exenatide Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Exenatide Sales Market Share by Country/Region (2024)
Figure 8. Exenatide Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Exenatide Market Size Market Share by Type in 2024
Figure 10. Exenatide in Hospital
Figure 11. Global Exenatide Market: Hospital (2020-2025) & ($ millions)
Figure 12. Exenatide in Drug store
Figure 13. Global Exenatide Market: Drug store (2020-2025) & ($ millions)
Figure 14. Global Exenatide Market Size Market Share by Application in 2024
Figure 15. Global Exenatide Revenue Market Share by Player in 2024
Figure 16. Global Exenatide Market Size Market Share by Region (2020-2025)
Figure 17. Americas Exenatide Market Size 2020-2025 ($ millions)
Figure 18. APAC Exenatide Market Size 2020-2025 ($ millions)
Figure 19. Europe Exenatide Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Exenatide Market Size 2020-2025 ($ millions)
Figure 21. Americas Exenatide Value Market Share by Country in 2024
Figure 22. United States Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Exenatide Market Size Market Share by Region in 2024
Figure 27. APAC Exenatide Market Size Market Share by Type (2020-2025)
Figure 28. APAC Exenatide Market Size Market Share by Application (2020-2025)
Figure 29. China Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 33. India Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Exenatide Market Size Market Share by Country in 2024
Figure 36. Europe Exenatide Market Size Market Share by Type (2020-2025)
Figure 37. Europe Exenatide Market Size Market Share by Application (2020-2025)
Figure 38. Germany Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 39. France Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Exenatide Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Exenatide Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Exenatide Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Exenatide Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Exenatide Market Size 2026-2031 ($ millions)
Figure 52. APAC Exenatide Market Size 2026-2031 ($ millions)
Figure 53. Europe Exenatide Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Exenatide Market Size 2026-2031 ($ millions)
Figure 55. United States Exenatide Market Size 2026-2031 ($ millions)
Figure 56. Canada Exenatide Market Size 2026-2031 ($ millions)
Figure 57. Mexico Exenatide Market Size 2026-2031 ($ millions)
Figure 58. Brazil Exenatide Market Size 2026-2031 ($ millions)
Figure 59. China Exenatide Market Size 2026-2031 ($ millions)
Figure 60. Japan Exenatide Market Size 2026-2031 ($ millions)
Figure 61. Korea Exenatide Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Exenatide Market Size 2026-2031 ($ millions)
Figure 63. India Exenatide Market Size 2026-2031 ($ millions)
Figure 64. Australia Exenatide Market Size 2026-2031 ($ millions)
Figure 65. Germany Exenatide Market Size 2026-2031 ($ millions)
Figure 66. France Exenatide Market Size 2026-2031 ($ millions)
Figure 67. UK Exenatide Market Size 2026-2031 ($ millions)
Figure 68. Italy Exenatide Market Size 2026-2031 ($ millions)
Figure 69. Russia Exenatide Market Size 2026-2031 ($ millions)
Figure 70. Egypt Exenatide Market Size 2026-2031 ($ millions)
Figure 71. South Africa Exenatide Market Size 2026-2031 ($ millions)
Figure 72. Israel Exenatide Market Size 2026-2031 ($ millions)
Figure 73. Turkey Exenatide Market Size 2026-2031 ($ millions)
Figure 74. Global Exenatide Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Exenatide Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Exenatide Market Size 2026-2031 ($ millions)